Table 2.

Disease specific costs and utilities used in the economic model.

	Costs		Utilities
Disease	Both sexes	Source	Male	Female	Source
CHD	£2838.70a	NHS 2015 – Proposed National Standards and Liu et al. (2002) [45, 46]	0.76	0.76	Laires et al. (2015) [47]
Stroke	£1627.26b	Saka et al. (2009) [48]	0.713	0.713	Rivero-Arias et al. (2010) [49]
Hypertension	£493.15b	Brilleman et al. (2013) [50]	0.721	0.721	Sullivan et al. (2011) [51]
T2DM	£672.28a	Minassian et al. (2012) and Kanavos et al. (2012) [52, 53]	0.661	0.661	Sullivan et al. (2011) [51]
Knee Osteoarthritis	£223.97b	Chen et al. (2012) [54]	0.49	0.46	Conner-Spady et al. (2015) [55]
Breast Cancer	£13,295.53b	Hall et al. (2015) [56]	N/A	0.749	Sullivan et al. (2011) [51]
Colorectal Cancer	£13,563.22b	Hall et al. (2015) [56]	0.676	0.676	Sullivan et al. (2011) [51]
Endometrial Cancer	£2471.21b	Pennington et al. (2016) [57]	N/A	0.598	Sullivan et al. (2011) [51]
Oesophageal Cancer	£9568.28b	Agus et al. (2013) [58]	0.904	0.904	Sullivan et al. (2011) [51]
Ovarian Cancer	£1408.94c	NHS programme budget [26]	N/A	0.848	Sullivan et al. (2011) [51]
Pancreatic Cancer	£5735.93b	Laudicello (2011) [59]	0.79	0.79	Romanus et al. (2012) [60]
Renal Cancer	£414.81c	NHS programme budget [26]	0.661	0.661	Sullivan et al. (2011) [51]

CHD Coronary Heart Disease, N/A Not Applicable, NHS National Health Service, T2DM Type 2 Diabetes Mellitus.

^aCosts estimated from study using top-down approach.

^bCosts estimated from study using bottom-up approach.

^cCosts estimated from programme budgets from 2012 inflated to 2016 values.